| Date Filed | Type | Description |
| 10/04/2023 |
SC 13G
| Knoll Capital Management, LLC reports a 6.1% stake in Aldeyra Therapeutics Inc |
| 01/23/2023 |
SC 13G
| Knoll Capital Management, LLC reports a 7.2% stake in Applied Therapeutics Inc. |
| 06/14/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G/A
| Knoll Capital Management, LP reports a 7.1% stake in Corbus Pharmaceuticals Holdings, Inc. |
| 02/14/2019 |
SC 13G/A
| Knoll Capital Management, LP reports a 7.9% stake in Corbus Pharmaceuticals Holdings, Inc. |
| 02/14/2018 |
SC 13G/A
| Knoll Capital Management, LP reports a 6.9% stake in Corbus Pharmaceuticals Holdings, Inc. |
| 02/14/2018 |
SC 13G/A
| Knoll Capital Management, LP reports a 5% stake in Abeona Therapeutics, Inc |
| 11/13/2017 |
SC 13G
| Knoll Capital Management, LP reports a 9.9% stake in Soligenix, Inc. |
| 03/06/2017 |
SC 13G/A
| Knoll Capital Management, LP reports a 7.3% stake in Corbus Pharmaceuticals Holdings, Inc. |
| 02/14/2017 |
SC 13G/A
| Corbus Pharmaceuticals Holdings, Inc. reports a 5.8% stake in _)* Corbus Pharmaceuticals Holdings, Inc. |
| 02/14/2017 |
SC 13G/A
| Knoll Capital Management, LP reports a 5.8% stake in _)* Corbus Pharmaceuticals Holdings, Inc. |
| 02/14/2017 |
SC 13G/A
| Knoll Capital Management, LP reports a 8.2% stake in Ritter Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| ALCOBRA LTD. reports a 4.4% stake in Alcobra Ltd, |
| 02/14/2017 |
SC 13G/A
| Ampio Pharmaceuticals, Inc. reports a 4.8% stake in Ampio Pharmaceuticals, Inc |
| 02/14/2017 |
SC 13G/A
| Synthetic Biologics, Inc. reports a 2.6% stake in Synthetic Biologics, Inc. |
| 11/04/2016 |
SC 13G
| Knoll Capital Management, LP reports a 8.9% stake in Ritter Pharmaceuticals, Inc. |
| 11/04/2016 |
SC 13G
| Knoll Capital Management, LP reports a 6.1% stake in Abeona Therapeutics, Inc |
| 10/05/2016 |
SC 13G
| RITTER PHARMACEUTICALS INC reports a 6.1% stake in Ritter Pharmaceuticals, Inc. |
| 03/01/2016 |
SC 13G
| Ampio Pharmaceuticals, Inc. reports a 6.5% stake in Ampio Pharmaceuticals, Inc |
| 03/01/2016 |
SC 13G
| Knoll Capital Management, LP reports a 5.2% stake in Synthetic Biologics, Inc. |
| 05/29/2013 |
SC 13G
| ALCOBRA LTD. reports a 5.3% stake in _)* Alcobra Ltd, |
| 01/14/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 02/11/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2011 |
SC 13G/A
| MEDIVATION, INC. reports a 5.7% stake in Medivation, Inc. |
| 12/07/2009 |
SC 13D
| Knoll Capital Management, LP reports a 29.1% stake in ALFACELL CORPORATION |
| 02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |